Next Generation Drugs. New Targets and Innovative Approaches for High-unmet Need Epileptic Disorders
Vice President and Biotech AnalystÂ
— 13 October, 2022
Vice President and Biotech AnalystÂ
Senior Biotech Analyst,Â
Vice President and Biotech Analyst,Â
Senior Biotech AnalystÂ
Thank you to all who joined Cantor’s
“Multiple Myeloma & Lymphoma”
“New Drug Discovery, Development
“Leukemia & MDS” was moderated byÂ
“Drug Development for Blood Disorders”
“Tackling the Tumor Microenvironment
Cantor’s 2022 brain week continues
Managing Director and Senior Biotech